Medical Marijuana Inc. President Michael Llamas and Director Tripp Keber Appeared on Recent Internet Radio Programs Segments Aired Tuesday, August 7th and Now Fully Archived

SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to announce that yesterday Company President, Michael Llamas was a special guest for a live on-air segment with Stock Traders Talk Radio.  Further, Company Director, Tripp Keber was also on the radio with a segment on the Sirius XM Radio Network's iCannabis Channel last evening. 

Mr. Llamas Interview Archived

The show aired on Tuesday, August 7th at 12 o'clock noon Pacific Time and is now archived on the www.stocktraderstalk.com internet radio network.  A link is also provided by scrolling down on the home page of the www.investorshub.com website, or by clicking here:  Interview  

Mr. Llamas covered a wide range of topics and put together, in a clear and succinct fashion, many of the individual pieces that form Medical Marijuana Inc.  In the interview he gives an in-depth look at present developments and the future for Medical Marijuana Inc. and Company shareholders / potential investors.  Mr. Llamas covered operations of the Medical Marijuana Inc subsidiary portfolio companies, including PhytoSPHERE Systems, Wellness Managed Services, Dixie & Red Dice Holdings, HempMeds Rx and CanChew Bio-technologies Inc. 

Mr. Keber Interview Archived As Well

Mr. Keber, managing director for Dixie Elixirs, appeared on last night's Realm of Caring American Weed show on the iCannabis Radio channel.  The internet radio link is provided below where one can find the segment archived.  Mr. Keber spoke about the Dixie Elixir company plus the new Dixie X high concentration hemp-based CBD-infused product line and the association with Medical Marijuana Inc.  Other topics included the coming worldwide availability of the new Dixie X CBD-infused products.

A link to the program site on the internet would be found here: Interview

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:
Medical Marijuana Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Email: ssmith@smallcapvoice.com
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SOURCE Medical Marijuana Inc.



RELATED LINKS
http://www.medicalmarijuanainc.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.